The Longer-term Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia

被引：0
|
作者：
Raal, Frederick J.
Rosenson, Robert S.
Reeskamp, Laurens F.
Hovingh, G. Kees
Kastelein, John J.
Rubba, Paolo
Ali, Shazia
Banerjee, Poulabi
Chan, Kuo-Chen
Khilla, Nagwa
Pordy, Robert
Zhang, Yi
Gaudet, Daniel
机构：
来源：
CIRCULATION | 2020年 / 142卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A14407
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Evinacumab Approval Adds a New Option for Homozygous Familial Hypercholesterolemia With a Hefty Price Tag
    Kuehn, Bridget M.
    CIRCULATION, 2021, 143 (25) : 2494 - 2496
  • [42] LONG-TERM SAFETY AND EFFICACY OF LOMITAPIDE IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: THREE-YEAR DATA FROM LOWER
    Underberg, James
    Cannon, Christopher P.
    Larrey, Dominique
    Makris, Lukas
    Jurecka, Agnieszka
    Blom, Dirk
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 24 - 24
  • [43] SAFETY AND EFFICACY OF EVINACUMAB, A MONOCLONAL ANTIBODY TO ANGPTL3, IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: A SINGLE-ARM, OPEN-LABEL, PROOF-OF-CONCEPT STUDY
    Gaudet, D.
    Gipe, D. A.
    Khoury, E.
    Pordy, R.
    Sasiela, W.
    Chan, K. C.
    ATHEROSCLEROSIS, 2016, 252 : E254 - E255
  • [44] Comparison of Model-Predicted and Observed Evinacumab Pharmacokinetics and Efficacy in Children Aged < 5 Years With Homozygous Familial Hypercholesterolemia
    Bihorel, Sebastien
    Dingman, Robert
    Mendell, Jeanne
    Norman, Katy C.
    George, Richard T.
    Zhao, Xue-Qiao
    Pordy, Robert
    Garcia, Daniel
    Putnam, Wendy S.
    Raghuveer, Geetha
    Mccrindle, Brian W.
    Fornari, Elena
    Baric, Ivo
    Srinivasan, Shubha
    Diamond, Melissa
    Brinton, Eliot A.
    Davis, John D.
    Dicioccio, A. Thomas
    Harnisch, Lutz
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2025,
  • [45] SAFETY AND EFFICACY OF EVINACUMAB, A MONOCLONAL ANTIBODY TO ANGPTL3, IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: A SINGLE-ARM, OPEN-LABEL, PROOF-OF-CONCEPT STUDY
    Gaudet, Daniel
    Gipe, Daniel
    Hovingh, Kees
    Ahmad, Zahid
    Cuchel, Marina
    Shah, Prediman
    Chyu, Kuang-Yuh
    Pordy, Robert
    Sasiela, William
    Chan, Kuo-Chen
    Khoury, Etienne
    ATHEROSCLEROSIS, 2017, 263 : E9 - E9
  • [46] Efficacy and safety of lipoprotein apheresis in children with homozygous familial hypercholesterolemia: A systematic review
    Luirink, Ilse K.
    Determeijer, Jim
    Hutten, Barbara A.
    Wiegman, Albert
    Bruckert, Eric
    Schmitt, Claus P.
    Groothoff, Jaap W.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2019, 13 (01) : 31 - 39
  • [47] Efficacy and Safety of Alirocumab in Adults With Homozygous Familial Hypercholesterolemia The ODYSSEY HoFH Trial
    Blom, Dirk J.
    Harada-Shiba, Mariko
    Rubba, Paolo
    Gaudet, Daniel
    Kastelein, John J. P.
    Charng, Min-Ji
    Pordy, Robert
    Donahue, Stephen
    Ali, Shazia
    Dong, Yuping
    Khilla, Nagwa
    Banerjee, Poulabi
    Baccara-Dinet, Marie
    Rosenson, Robert S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (02) : 131 - 142
  • [48] Efficacy and Safety of Evinacumab for the Treatment of Hypercholesterolemia: A Meta-Analysis
    Jin, Menglong
    Meng, Fanhua
    Yang, Wenwen
    Liang, Liyan
    Wang, Hao
    Fu, Zhenyan
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2021, 78 (03) : 394 - 402
  • [49] Long-Term Safety and Efficacy of Low-Density Lipoprotein Apheresis in Childhood for Homozygous Familial Hypercholesterolemia
    Hudgins, Lisa C.
    Kleinman, Bryan
    Scheuer, Abby
    White, Sharon
    Gordon, Bruce R.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (09): : 1199 - 1204
  • [50] Longer-term Safety of Ofatumumab in Patients With Relapsing Multiple Sclerosis
    Sacca, F.
    Hauser, S.
    Cross, A.
    Winthrop, K.
    Wiendl, H.
    Nicholas, J.
    Meuth, S.
    Giacomini, P.
    Zielman, R.
    Hu, X.
    Gupta, A.
    Sullivan, R.
    DeLasHeras, V.
    Su, W.
    Kappos, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 152 - 152
12345